EFFECTS OF THERAPY ON THE ABILITY OF ERYTHROCYTES FLUVASTATIN AGGREGATION IN HYPERTENSIVE PATIENTS WITH DYSLIPIDEMIA
Aim: investigate the possible influence of fluvastatin on erythrocyte aggregation in hypertensive patients with dyslipidemia. Material and methods: under a supervision there were 32 patients by arterial high blood pressure 1-2 degrees, risk 3 (criteria of DAG3 (2008) with dyslipidemia II6 of type),...
Saved in:
| Main Authors: | I. N. Medvedev, I. A. Skorjatina |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
InterMedservice
2012-03-01
|
| Series: | Евразийский Кардиологический Журнал |
| Subjects: | |
| Online Access: | https://www.heartj.asia/jour/article/view/5438 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
FLUVASTATIN EFFECTS ON BLOOD CELL AGGREGATION IN PATIENTS WITH ARTERIAL HYPERTENSION AND DYSLIPIDEMIA
by: I. N. Medvedev, et al.
Published: (2013-04-01) -
STATE CONTROL OF THE VASCULAR WALL TO ANTIAGGREGATIVE BY NEUTROPHILS IN PATIENTS ARTERIAL HYPERTENSION WITH DYSLIPIDEMIA PATIENTS TREATED WITH SIMVASTATIN
by: I. N. Medvedev, et al.
Published: (2013-03-01) -
Effects of fluvastatin, valsartan, and their combination on endothelial function in patients with arterial hypertension and dyslipidemia
by: T. Sh. Mirilashvili, et al.
Published: (2009-08-01) -
MICRORHEOLOGY OF ERYTHROCYTES IN ARTERIAL HYPERTENSION AND DYSLIPIDEMIA WITH A COMPLEX HYPOLIPIDEMIC TREATMENT
by: I. N. Medvedev
Published: (2017-05-01) -
ACE inhibitors potential in correcting vessel wall anti-aggregation activity among patients with arterial hypertension and metabolic syndrome
by: I. N. Medvedev, et al.
Published: (2007-02-01)